News

27 Nov 2020

COG-UK researchers make highly cited list

COG-UK

Eight COG-UK Consortium members and associates have been recognised by Clarivate as some of the most highly cited researchers of 2020.

COVID-19 Genomics UK (COG-UK) Consortium members and associates Professor Andrew Rambaut of the University of Edinburgh, Professor Gordon Dougan of the University of Cambridge, Dr Jeffrey Barrett of the Wellcome Sanger Institute, Professor John Danesh of the University of Cambridge, Professor Julian Parkhill of the University of Cambridge, Dr Matthew Berriman of the Wellcome Sanger Institute, Professor Nicholas Loman of the University of Birmingham, and COG-UK Director Professor Sharon Peacock have been named in the annual Highly Cited Researchers 2020 list from Clarivate.

The list identifies scientists who have demonstrated significant and broad influence in their chosen field, reflected through the publication of multiple papers frequently cited by their peers during the last decade. Researchers’ names are drawn from the publications that rank in the top one per cent by citations for field and year in the Web of Science citation index.

We congratulate those Consortium members and associates who made the list for their significant impact on the research community.

This year, 6,389 scientists have been named as Highly Cited Researchers — of which 513 are from the UK. The methodology that determines these influential researchers draws on the data and analysis performed by bibliometric experts and data scientists at the Institute for Scientific Information at Clarivate.

View the full list of Highly Cited Researchers 2020.

 

 

COVID-19 Genomics UK (COG-UK)

The current COVID-19 pandemic, caused by the SARS-CoV-2, represents a major threat to health. The COVID-19 Genomics UK (COG-UK) consortium has been created to deliver large-scale and rapid whole-genome virus sequencing to local NHS centres and the UK government.

Led by Professor Sharon Peacock of the University of Cambridge, COG-UK is made up of an innovative partnership of NHS organisations, the four Public Health Agencies of the UK, the Wellcome Sanger Institute and twelve academic partners providing sequencing and analysis capacity. A full list of collaborators can be found here: https://www.cogconsortium.uk/about/. Professor Peacock is also on a part-time secondment to PHE as Director of Science, where she focuses on the development of pathogen sequencing through COG-UK.

COG-UK was established in March 2020 supported by £20 million funding from the UK Department of Health and Social Care (DHSC), UK Research and Innovation (UKRI) and the Wellcome Sanger Institute, administered by UK Research and Innovation.


COVID-19 Genomics UK (COG-UK)

The COVID-19 Genomics UK (COG-UK) consortium works in partnership to harness the power of SARS-CoV-2 genomics in the fight against COVID-19.

Led by Professor Sharon Peacock of the University of Cambridge, COG-UK is made up of an innovative collaboration of NHS organisations, the four public health agencies of the UK, the Wellcome Sanger Institute and sixteen academic partners. A full list of collaborators can be found here.

The COVID-19 pandemic, caused by SARS-CoV-2, represents a major threat to health. The COG-UK consortium was formed in March 2020 to deliver SARS-CoV-2 genome sequencing and analysis to inform public health policy and to support the establishment of a national pathogen sequencing service, with sequence data now predominantly generated by the Wellcome Sanger Institute and the Public Health Agencies.

SARS-CoV-2 genome sequencing and analysis plays a key role in the COVID-19 public health response by enabling the identification, tracking and analysis of variants of concern, and by informing the design of vaccines and therapeutics. COG-UK works collaboratively to deliver world-class research on pathogen sequencing and analysis, maximise the value of genomic data by ensuring fair access and data linkage, and provide a training programme to enable equity in global sequencing.